NO20005681L - New formulations containing paroxetine - Google Patents
New formulations containing paroxetineInfo
- Publication number
- NO20005681L NO20005681L NO20005681A NO20005681A NO20005681L NO 20005681 L NO20005681 L NO 20005681L NO 20005681 A NO20005681 A NO 20005681A NO 20005681 A NO20005681 A NO 20005681A NO 20005681 L NO20005681 L NO 20005681L
- Authority
- NO
- Norway
- Prior art keywords
- formulations containing
- new formulations
- containing paroxetine
- paroxetine
- hemihydrate
- Prior art date
Links
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 3
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229960002296 paroxetine Drugs 0.000 title 1
- 239000002775 capsule Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229960005183 paroxetine hydrochloride Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Paroxetinhydroklorid, i en annen form enn hemihydratet, som er anvendt i kapsler under slike betingelser at det ikke er noen påviselig omdannelse til hemihydrat under produksjonsprosessen.Paroxetine hydrochloride, in a form other than the hemihydrate, used in capsules under such conditions that there is no detectable conversion to hemihydrate during the production process.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9810180.1A GB9810180D0 (en) | 1998-05-13 | 1998-05-13 | Novel formulation |
| PCT/GB1999/001522 WO1999058116A2 (en) | 1998-05-13 | 1999-05-13 | Novel formulation containing paroxetine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005681D0 NO20005681D0 (en) | 2000-11-10 |
| NO20005681L true NO20005681L (en) | 2000-12-01 |
Family
ID=10831926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005681A NO20005681L (en) | 1998-05-13 | 2000-11-10 | New formulations containing paroxetine |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1077685A2 (en) |
| JP (1) | JP2002514593A (en) |
| KR (1) | KR20010043545A (en) |
| CN (1) | CN1309557A (en) |
| AP (1) | AP2000001985A0 (en) |
| AU (1) | AU3941099A (en) |
| BG (1) | BG105011A (en) |
| BR (1) | BR9910402A (en) |
| CA (1) | CA2331849A1 (en) |
| EA (1) | EA200001173A1 (en) |
| GB (1) | GB9810180D0 (en) |
| HU (1) | HUP0101931A3 (en) |
| ID (1) | ID27018A (en) |
| IL (1) | IL139596A0 (en) |
| NO (1) | NO20005681L (en) |
| PL (1) | PL344872A1 (en) |
| SK (1) | SK16972000A3 (en) |
| TR (1) | TR200003351T2 (en) |
| WO (1) | WO1999058116A2 (en) |
| ZA (1) | ZA200006465B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000054775A1 (en) * | 1999-03-12 | 2000-09-21 | Basf Ag | Stable pharmaceutical application form for paroxetin anhydrate |
| HU226912B1 (en) * | 2000-04-07 | 2010-03-01 | Richter Gedeon Nyrt | New paroxetin salt and medicament containing it |
| JP6062422B2 (en) * | 2012-03-29 | 2017-01-18 | 杏林製薬株式会社 | Capsule formulation |
| DE102013207447A1 (en) | 2013-04-24 | 2014-10-30 | Evonik Degussa Gmbh | Process and apparatus for the preparation of octachlorotrisilane |
| CN103520131B (en) * | 2013-10-12 | 2019-05-14 | 浙江华海药业股份有限公司 | The preparation method of paroxetine hydrochloride semihydrate capsule |
| CN103961333B (en) * | 2014-05-07 | 2020-02-21 | 浙江华海药业股份有限公司 | Paroxetine mesylate capsule and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996031197A1 (en) * | 1995-04-03 | 1996-10-10 | Abbott Laboratories | Homogeneous mixtures of low temperature-melting drugs and additives for controlled release |
| GB9724544D0 (en) * | 1997-11-21 | 1998-01-21 | Smithkline Beecham Plc | Novel Formulation |
-
1998
- 1998-05-13 GB GBGB9810180.1A patent/GB9810180D0/en not_active Ceased
-
1999
- 1999-05-13 JP JP2000547967A patent/JP2002514593A/en active Pending
- 1999-05-13 HU HU0101931A patent/HUP0101931A3/en unknown
- 1999-05-13 KR KR1020007012660A patent/KR20010043545A/en not_active Withdrawn
- 1999-05-13 EA EA200001173A patent/EA200001173A1/en unknown
- 1999-05-13 CN CN99808548A patent/CN1309557A/en active Pending
- 1999-05-13 WO PCT/GB1999/001522 patent/WO1999058116A2/en not_active Ceased
- 1999-05-13 AU AU39410/99A patent/AU3941099A/en not_active Abandoned
- 1999-05-13 TR TR2000/03351T patent/TR200003351T2/en unknown
- 1999-05-13 BR BR9910402-4A patent/BR9910402A/en not_active Application Discontinuation
- 1999-05-13 SK SK1697-2000A patent/SK16972000A3/en unknown
- 1999-05-13 EP EP99922303A patent/EP1077685A2/en not_active Withdrawn
- 1999-05-13 IL IL13959699A patent/IL139596A0/en unknown
- 1999-05-13 AP APAP/P/2000/001985A patent/AP2000001985A0/en unknown
- 1999-05-13 PL PL99344872A patent/PL344872A1/en unknown
- 1999-05-13 CA CA002331849A patent/CA2331849A1/en not_active Abandoned
- 1999-05-13 ID IDW20002329A patent/ID27018A/en unknown
-
2000
- 2000-11-09 ZA ZA200006465A patent/ZA200006465B/en unknown
- 2000-11-10 NO NO20005681A patent/NO20005681L/en not_active Application Discontinuation
- 2000-11-30 BG BG105011A patent/BG105011A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA200001173A1 (en) | 2001-04-23 |
| NO20005681D0 (en) | 2000-11-10 |
| JP2002514593A (en) | 2002-05-21 |
| ID27018A (en) | 2001-02-22 |
| EP1077685A2 (en) | 2001-02-28 |
| ZA200006465B (en) | 2001-11-09 |
| CN1309557A (en) | 2001-08-22 |
| TR200003351T2 (en) | 2001-03-21 |
| GB9810180D0 (en) | 1998-07-08 |
| SK16972000A3 (en) | 2001-06-11 |
| PL344872A1 (en) | 2001-11-19 |
| WO1999058116A3 (en) | 2000-02-17 |
| KR20010043545A (en) | 2001-05-25 |
| BG105011A (en) | 2001-07-31 |
| BR9910402A (en) | 2001-01-09 |
| WO1999058116A2 (en) | 1999-11-18 |
| AU3941099A (en) | 1999-11-29 |
| HUP0101931A3 (en) | 2002-10-28 |
| HUP0101931A2 (en) | 2002-04-29 |
| CA2331849A1 (en) | 1999-11-18 |
| IL139596A0 (en) | 2002-02-10 |
| AP2000001985A0 (en) | 2000-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199800140A1 (en) | Paroxetine controlled release compositions | |
| ATE256175T1 (en) | MULTI-PHASE DETERGENT TABLETS AND METHOD FOR THE PRODUCTION THEREOF | |
| EP0680328A1 (en) | TOPICAL KETOCONAZOLE MEDICINAL PRODUCT. | |
| HUP9903741A2 (en) | N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect | |
| MXPA03004386A (en) | Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds. | |
| ES2137549T3 (en) | ANTIFUNGAL DERIVATIVES OF SORDARIDINE. | |
| EA200400455A1 (en) | METHOD FOR PREPARING A QUICKLY SOLUBLE DOSAGE FORM | |
| NO20005681L (en) | New formulations containing paroxetine | |
| GEP20063972B (en) | Streptogramin derivatives, preparation and compositions containing them | |
| NO960464L (en) | Redispersible, powdery core-shell polymers, their preparation and use | |
| YU45395A (en) | A NEW CHEMICAL UNIT, ITS PREPARATION AND ITS APPLICATION AS A MEDICINE | |
| MEP5808A (en) | Escitalopram hydrobromide and a method for the preparation thereof | |
| DK0755919T3 (en) | Substituted cinnamic acid guanides, process for their preparation, their use as cardiovascular drug e | |
| NO20005683L (en) | New formulation containing paroxetine | |
| AR002737A1 (en) | NEW PROCEDURE FOR THE PREPARATION OF ROPIVACAINE CHLORHYDRATE MONOHYDRATE AND SUCH MONOHYDRATE PREPARED BY THE ABOVE PROCEDURE. | |
| PL356523A1 (en) | Substituted 1 and 2 naphthol mannich bases | |
| BR9900057B1 (en) | method for the modernization of a heterogeneously synthesized reactor on site. | |
| NO971851L (en) | Child-safe packaging for active ingredient-containing plastics | |
| DK0863880T3 (en) | New, anti-convulsant-acting 1-ar (alk) yl imidazolin-2-ones containing a disubstituted amine residue at the 4-position, and process for their preparation | |
| MY122830A (en) | Process for the preparation of (alpha)-(2-4-disulfophenyl)-n-tert-butylnitrone and pharmaceutically acceptable salts thereof | |
| NO20000199L (en) | Medications containing polyhydroxybutylpyrazines, new polyhydroxybutylpyrazines and their preparation | |
| DK1157020T3 (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-2-benzazocin-10-ols, processes for their preparation and their use as a drug | |
| HUT77439A (en) | A new method for producing ranitidine | |
| DK120889A (en) | 3- (2,3,4,5,6-PENTAFLUORPHENOXY) -8-AZABICYCLOOE3.2.1AAOCTANES, A PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS MEDICINES | |
| ATE243695T1 (en) | 5-BICYCLOINDOLE COMPOUNDS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |